atorvastatin has been researched along with bisoprolol in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (8.33) | 29.6817 |
2010's | 8 (66.67) | 24.3611 |
2020's | 3 (25.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Peters, GJ; Schneiders, FL; van den Berg, HP; van der Vliet, HJ; Verheul, HM | 1 |
Murphy, G; Murphy, JEJ; O'Gorman, SM; Powers, JM; Ralph, N | 1 |
Bayliss, M; Fontana, V; Pirmohamed, M; Santoyo Castelazo, A; Turner, RM; Whalley, S | 1 |
Finsterer, J; Stollberger, C | 1 |
Dukhovskaya, NE; Gorbacheva, SY; Gremyakova, PV; Ostrovskaya, IG; Vavilova, TP | 1 |
Bando, Y; Ishii, H; Otori, K; Yokota, N | 1 |
Abdel-Monem, AH; Abdel-Raoof, AM; Attia, KAM; Eissa, AS | 1 |
Kawasaki, N; Mizuno, Y; Nishida, K; Ogata, F; Uematsu, Y | 1 |
1 review(s) available for atorvastatin and bisoprolol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for atorvastatin and bisoprolol
Article | Year |
---|---|
Development, validation and application of a novel HPLC-MS/MS method for the quantification of atorvastatin, bisoprolol and clopidogrel in a large cardiovascular patient cohort.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Bisoprolol; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Clopidogrel; Cohort Studies; Female; Humans; Male; Mass Spectrometry; Platelet Aggregation Inhibitors; Prospective Studies; Reproducibility of Results; Tandem Mass Spectrometry; Ticlopidine | 2018 |
10 other study(ies) available for atorvastatin and bisoprolol
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Severe toxicity of capecitabine following uncomplicated treatment with 5-fluorouracil/leucovorin.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Atorvastatin; Bisoprolol; Bone Neoplasms; Capecitabine; Colic; Colorectal Neoplasms; Deoxycytidine; Female; Fluorouracil; Heptanoic Acids; Humans; Hypercholesterolemia; Ileus; Leucovorin; Lymphatic Metastasis; Middle Aged; Nausea; Pyrroles; Ventricular Premature Complexes; Vomiting | 2011 |
Polypharmacy and sun exposure: Implications for mitochondrial DNA deletions in skin.
Topics: Aged; Allopurinol; Atorvastatin; Bisoprolol; Cholesterol; DNA Damage; DNA, Mitochondrial; Gene Deletion; Humans; Mitochondria; Perindopril; Pravastatin; Real-Time Polymerase Chain Reaction; Skin; Ubiquinone; Ultraviolet Rays | 2017 |
Simultaneous transient global amnesia and Takotsubo syndrome after death of a relative: a case report.
Topics: Amnesia, Transient Global; Antihypertensive Agents; Aspirin; Atorvastatin; Benzimidazoles; Biphenyl Compounds; Bisoprolol; Coronary Angiography; Electrocardiography; Fibrinolytic Agents; Grief; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Middle Aged; Myocarditis; Stress, Psychological; Takotsubo Cardiomyopathy; Tetrazoles; Treatment Outcome | 2019 |
[Application of the method of liquid chromato-mass spectrometry for determination of bisoprolol and atorvastatin.]
Topics: Atorvastatin; Bisoprolol; Chromatography, Liquid; Humans; Mass Spectrometry; Reproducibility of Results; Saliva | 2019 |
[Significant Prolongation of the International Normalized Ratio Associated with COVID-19 Treatment: Possible Drug Interaction with Remdesivir].
Topics: Adenosine Monophosphate; Alanine; Amiodarone; Anticoagulants; Atorvastatin; Bisoprolol; COVID-19 Drug Treatment; Dexamethasone; Diltiazem; Drug Interactions; Humans; International Normalized Ratio; Male; Middle Aged; Warfarin | 2022 |
Novel Deconvoluted Synchronous Spectrofluorimetric Method For Simultaneous Determination Of Bisoprolol and Atorvastatin As Single or Co-administrated Drugs in Bulk and Plasma; Green Assessment.
Topics: Atorvastatin; Bisoprolol; Plasma; Quality Control; Spectrometry, Fluorescence | 2023 |
Potential Interaction between Sodium Polystyrene Sulfonate and Prescription Drugs in Artificial Intestinal Juice.
Topics: Atorvastatin; Bisoprolol; Carvedilol; Potassium; Prescription Drugs | 2023 |